Efficacy and Safety of Ferrous Iron on the Prevention of Vascular Cognitive Impairment Among Patients With Cerebral Infarction/TIA (FAVORITE)
A phase 2 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 1006 participants.
Also called NCT03891277
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 1,006 participants
- Sponsor
- Registry
-
NCT03891277
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Unknown status
Technical summary
Registry record NCT03891277. Randomized; quadruple masking; primary purpose treatment. Start 2019-04-01 (actual); primary completion 2021-10-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Efficacy and Safety of Ferrous Iron on the Prevention of Vascular Cognitive Impairment Among Patients With Cerebral Infarction/TIA (FAVORITE)
- Acronym
- FAVORITE
- Condition
- Vascular Cognitive Impairment
- Condition
- Dementia, Vascular
- Condition
- Iron-deficiency
- Condition
- Cerebral Infarction
- Condition
- TIA (transient ischemic attack)
- Intervention (Drug)
- Ferrous succinate
- Lead sponsor
- Beijing Tiantan Hospital
Record details
- Record id
cardio:ct-nct03891277- Content hash
aaaa1d45fdd43fde0c427bf850d1741569752eecce797db34e764f0054168c50